-
Sitagliptin, sold
under the
brand name
Januvia among others, is an anti-diabetic
medication used to
treat type 2 diabetes. In the
United Kingdom it is...
-
Sitagliptin/metformin, sold
under the
brand name
Janumet among others, is a fixed-dose
combination anti-diabetic
medication used to
treat type 2 diabetes...
- Dapagliflozin/
sitagliptin, sold
under the
brand name Sidapvia, is a fixed-dose
combination anti-diabetic
medication used for the
treatment of type 2 diabetes...
- used to
treat diabetes mellitus type 2. The
first agent of the
class –
sitagliptin – was
approved by the FDA in 2006.
Glucagon increases blood glucose levels...
- for use as a
monotherapy and as a
fixed dose
combination with
either sitagliptin or with metformin. In the
European Union, it was
approved in
March 2018...
-
incretins and
various combinations.
Sitagliptin patent expired in July 2022,
leading to
launch of
generic sitagliptin brands . This
lowered the cost of...
-
twice daily,
sitagliptin and rosiglitazone. In a
randomized controlled trial (RCT)
comparing liraglutide, glargine, glimepiride, and
sitagliptin (all added...
-
Milicevic Z (August 2014). "Efficacy and
safety of
dulaglutide versus sitagliptin after 52 w****s in type 2
diabetes in a
randomized controlled trial (AWARD-5)"...
-
Sitagliptin/simvastatin, sold
under the
brand name Juvisync, is a fixed-dose
combination anti-diabetic
medication used to
treat type 2
diabetes and hypercholesterolemia...
-
December 2024. "Efficacy and
Safety of
Semaglutide Once-w****ly
Versus Sitagliptin Once-daily as add-on to
Metformin and/or TZD in
Subjects With Type 2...
